This review emphasizes the importance of recognizing and managing genetic lipoprotein disorders to mitigate the long-term risk of atherosclerotic vascular disease.
No takes yet. Share an insight, caveat, or question.
May inform genetic evaluation in familial CAD; leaves open prospective validation of novel HDL disorders.
Jacques Genest (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: